41 reports

  • 7.2. HOW WAS THE HEALTHCARE LANDSCAPE CHANGING IN 2019?
  • Belgium healthcare providers sector category segmentation: % share, by value, 2019

Table ##: Belgium healthcare providers sector value: $ billion, 2015-## Figure ##: Belgium healthcare providers sector value: $ billion, 2015-## ##.

  • Healthcare
  • Belgium
  • Market Size
  • Korian Group
  • ORPEA group

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Belgium
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: NETWORK SERVICES, USD
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: ENTERPRISE MOBILITY SERVICES,

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Belgium
  • Market Segment
  • Market Size
  • Belgium- Main Institutions of Social Security System .......................................................................................................................... 22
  • Belgium- Main Institutions of Social Security System

The social security system contains seven branches.

  • Healthcare
  • Medical Benefit
  • Pension
  • Belgium
  • Economy

Other sub-brands of Nan include Nan Satiété ## and ##, Nan Transit ## and ##, and Nan Evolia ## and ##.

  • Healthcare
  • Belgium
  • Market Size
  • Danone SA
  • Nestlé S.A.
  • TRIMB HEALTHCARE ACQUIRES OTC PRODUCTS FROM CILAG AND JANSSEN PHARMA

The company' s deal volume decreased from five pharmaceuticals & healthcare deals in 2016 to four pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Belgium
  • Company
  • Janssen Biotech, Inc.

GlobalData Omega Pharma NV, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Belgium
  • Corporate Finance
  • M&A
  • Omega

Following completion of the sequential dose escalation part, the remaining ## subjects will be randomly assigned in a ##:##:##:## ratio to one of the three dose groups of inhaled ALX-## (##. ## mg/ kg, ##. ## mg/ kg and ##. ## mg/ kg) or inhaled placebo

  • Healthcare
  • Belgium
  • Company
  • Company Financials
  • Ablynx NV

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Colorectal Cancer
  • Healthcare
  • Pharmaceutical
  • Belgium
  • VolitionRx Limited

It targets JAK ##.

  • Arthritis
  • Healthcare
  • Belgium
  • Company
  • Galapagos NV
  • EQUITY OFFERING

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Allergy
  • Healthcare
  • Belgium
  • Product Initiative
  • ASIT Biotech

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Belgium

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Belgium
  • Ghent University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Ghent University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

The center is fully operational as from December ##, 2012.

  • Healthcare
  • Pharmaceutical
  • Belgium
  • Deals & Alliance

One of these barriers is the blood-cerebrospinal fluid (CSF) barrier.

  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Belgium

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Belgium

GlobalData Debiopharm Innovation Fund SA, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Healthcare
  • Belgium
  • Company
  • Deals & Alliance
  • Debiopharm Group

GlobalData Deal Type Licensing Agreement Partnerships Venture Financing No. of Deals ## ## ## Deal Value (US$ million) NA NA NA Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals

  • Healthcare
  • Belgium
  • Deals & Alliance
  • Supply
  • Delphi Genetics SA
  • VENTURE FINANCING

GlobalData Camel-IDS NV, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Belgium
  • Company
  • Deals & Alliance
  • LICENSING AGREEMENTS

GlobalData eTheRNA Immunotherapies NV, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Belgium
  • Company
  • Deals & Alliance
  • eTheRNA

The drug candidates target Mucosa-associated lymphoid tissue lymphoma trans-location ## (MALT##).

  • Healthcare
  • Pharmaceutical
  • Belgium
  • Deals & Alliance

GlobalData Catholic University of Louvain, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Belgium
  • Netherlands
  • Company
  • Deals & Alliance
  • Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
  • Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

GlobalData Device Type HealthCare IT In Vitro Diagnostics Diagnostic Imaging Drug Delivery Devices No. of Deals ## ## ## ## Deal Value (US$ million) ##. ## ##. ## NA NA Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD ##

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Belgium
  • Deals & Alliance

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Belgium

Wipes in Belgium

800 990 650

Passport ## However, there are opportunities for disposable hygiene, with adult incontinence seeing uptake, as well as more demand for antibacterial wipes for surface and bodily fluid cleansing in healthcare.

  • Healthcare
  • Medical Equipment
  • Belgium

Other sub-brands of Nan include Nan Satiété ## and ##, Nan Transit ## and ##, and Nan Evolia ## and ##.

  • Healthcare
  • Belgium
  • Danone SA
  • Mondelez International, Inc.
  • Nestlé S.A.
  • HEALTHCARE SYSTEM
  • Belgium: Leading Corporate Groups

FUTURE DEVELOPMENTS Cost-containment measures impacting on healthcare (including pharmaceuticals) will be implemented on ## January 2017 in order to address a forecast overspend of some €## million on the 2016 healthcare budget.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Belgium
  • Price
  • JANSSEN PHARMACEUTICA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH SIEMENS HEALTHCARE DIAGNOSTICS
  • Feb 08, 2018: Belgium-Based JLINX Incubator to Transition to Johnson & Johnson Innovation JLABS, Expanding Outreach Across Europe

The company caters to Healthcare, Consumer Life Style, and Lighting industries.

  • Healthcare
  • Medical Device
  • Belgium
  • Deals & Alliance
  • Janssen Biotech, Inc.

One Maritime Plaza, Suite ## San Francisco California United States www. generation. com ## ## ## William Blair & Company, L. L. C.

  • Chronic Disease
  • Healthcare
  • Therapy
  • Belgium
  • Barco NV
  • Financial information - (Fiscal year 31-Dec-2006)
  • Financial information - (Fiscal year 31-Dec-2008)

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion Company type Stock exchange Ticker symbol Business description PARTNER ##: BIOLINERX LTD.

  • Healthcare
  • Belgium
  • Company
  • M&A
  • Omega